<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://social.eyeforpharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Sales</title>
 <link>http://social.eyeforpharma.com/category/channels/sales-sfe</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>How to get marketers and reps to work together</title>
 <link>http://social.eyeforpharma.com/story/how-get-marketers-and-reps-work-together</link>
 <description>&lt;P&gt;Pharma consultant Allan Dick on how to bridge the gap between sales strategy formation and sales strategy implementation&lt;/P&gt;
&lt;P&gt;Poor patient adherence is a well-documented problem for the pharmace&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/how-get-marketers-and-reps-work-together&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/how-get-marketers-and-reps-work-together#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe/sfe-strategy">SFE Strategy</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/channels/marketing">Marketing</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Thu, 24 Jun 2010 10:51:40 +0100</pubDate>
 <dc:creator>Andrew Tolve</dc:creator>
 <guid isPermaLink="false">8180 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>New sales force models: Get ready for the ‘hybrid reps’</title>
 <link>http://social.eyeforpharma.com/story/new-sales-force-models-get-ready-%E2%80%98hybrid-reps%E2%80%99</link>
 <description>&lt;P&gt;Mark Gleason, senior vice president of corporate development at Aptilon, explains how sales reps are combining field visits with online meetings.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/new-sales-force-models-get-ready-%E2%80%98hybrid-reps%E2%80%99&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/new-sales-force-models-get-ready-%E2%80%98hybrid-reps%E2%80%99#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/site-content/featured">Featured</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe/sfe-strategy">SFE Strategy</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Mon, 16 Aug 2010 10:27:38 +0100</pubDate>
 <dc:creator>Andrew Tolve</dc:creator>
 <guid isPermaLink="false">9856 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>The future of pharma: When it comes to strategy, one size does not fit all</title>
 <link>http://social.eyeforpharma.com/story/future-pharma-when-it-comes-strategy-one-size-does-not-fit-all</link>
 <description>&lt;P&gt;Effective strategies must match both the external market and the internal company culture.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/future-pharma-when-it-comes-strategy-one-size-does-not-fit-all&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/future-pharma-when-it-comes-strategy-one-size-does-not-fit-all#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe/sfe-strategy">SFE Strategy</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Mon, 16 Aug 2010 10:23:54 +0100</pubDate>
 <dc:creator>Dr Brian D Smith</dc:creator>
 <guid isPermaLink="false">9855 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>How US healthcare reform could change pharma</title>
 <link>http://social.eyeforpharma.com/story/how-us-healthcare-reform-could-change-pharma</link>
 <description>&lt;P&gt;Healthcare reform has made change in the pharma sector all the more urgent. Is the industry right to take a wait-and-see approach? Andrew Tolve investigates.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/how-us-healthcare-reform-could-change-pharma&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/how-us-healthcare-reform-could-change-pharma#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 20 Jul 2010 09:50:01 +0100</pubDate>
 <dc:creator>Andrew Tolve</dc:creator>
 <guid isPermaLink="false">8973 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>The future of pharma: managing complex markets</title>
 <link>http://social.eyeforpharma.com/story/future-pharma-managing-complex-markets</link>
 <description>&lt;P&gt;Pharma execs need to discard conventional thinking and prepare their organizations for bursts of sudden, dramatic change, argues Brian Smith.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/future-pharma-managing-complex-markets&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/future-pharma-managing-complex-markets#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 20 Jul 2010 09:44:17 +0100</pubDate>
 <dc:creator>Dr Brian D Smith</dc:creator>
 <guid isPermaLink="false">8972 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>What&#039;s next for sales reps?</title>
 <link>http://social.eyeforpharma.com/story/whats-next-sales-reps</link>
 <description>&lt;P&gt;Marcus Deans explains why summer’s here and the time is right for ...&amp;nbsp;rethinking the future of the sales rep.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/whats-next-sales-reps&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/whats-next-sales-reps#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 20 Jul 2010 09:41:40 +0100</pubDate>
 <dc:creator>Marcus Deans</dc:creator>
 <guid isPermaLink="false">8970 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>Can the Web replace the rep?</title>
 <link>http://social.eyeforpharma.com/story/can-web-replace-rep</link>
 <description>&lt;P&gt;Kate Wagstaff, product manager for Ferring Pharmaceuticals, on how to create an effective online campaign aimed at physicians.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/can-web-replace-rep&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/can-web-replace-rep#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe/sfe-strategy">SFE Strategy</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/channels/marketing">Marketing</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 13 Jul 2010 09:42:58 +0100</pubDate>
 <dc:creator>Les Rose</dc:creator>
 <guid isPermaLink="false">8736 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>Sales and marketing: Implementing new commercial models on the front-line</title>
 <link>http://social.eyeforpharma.com/story/sales-and-marketing-implementing-new-commercial-models-front-line</link>
 <description>&lt;P&gt;Paul Van Arkel, a principal with McKinsey &amp;amp; Company in Zurich, on how to make a multi-channel sales and marketing model work, region by region.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/sales-and-marketing-implementing-new-commercial-models-front-line&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/sales-and-marketing-implementing-new-commercial-models-front-line#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/channels/marketing">Marketing</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 13 Jul 2010 09:34:34 +0100</pubDate>
 <dc:creator>Andrew Tolve</dc:creator>
 <guid isPermaLink="false">8735 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>New sales models and market access</title>
 <link>http://social.eyeforpharma.com/story/new-sales-models-and-market-access</link>
 <description>&lt;P&gt;John Ferguson explores new ways to update pharma sales methods to improve market access.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/new-sales-models-and-market-access&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/new-sales-models-and-market-access#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe/sfe-strategy">SFE Strategy</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/marketaccess">Market Access</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 22 Jun 2010 10:06:22 +0100</pubDate>
 <dc:creator>John Ferguson</dc:creator>
 <guid isPermaLink="false">8128 at http://social.eyeforpharma.com</guid>
</item>
<item>
 <title>The future of pharma</title>
 <link>http://social.eyeforpharma.com/story/future-pharma</link>
 <description>&lt;P&gt;Brian Smith explores what the history of the pharma industry says about what’s to come.&lt;/P&gt;
&lt;P&gt;&lt;p&gt;&lt;a href=&quot;http://social.eyeforpharma.com/story/future-pharma&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://social.eyeforpharma.com/story/future-pharma#comments</comments>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe/sfe-strategy">SFE Strategy</category>
 <category domain="http://social.eyeforpharma.com/category/channels/sales-sfe">Sales</category>
 <category domain="http://social.eyeforpharma.com/category/location/global">Global</category>
 <pubDate>Tue, 22 Jun 2010 10:01:24 +0100</pubDate>
 <dc:creator>Dr Brian D Smith</dc:creator>
 <guid isPermaLink="false">8126 at http://social.eyeforpharma.com</guid>
</item>
</channel>
</rss>
